DOT Adds Synthetic Opioids to Drug Test Panel

DOT-regulated employers will be required to test for the opioids hydrocodone, hydromorphone, oxymorphone, and oxycodone starting on Jan. 1, 2018.

A final rule published Nov. 13 by the U.S. Department of Transportation will expand its drug testing panel to include hydrocodone, hydromorphone, oxymorphone, and oxycodone -- synthetic opioids that are highly abused, according to the agency -- for DOT-regulated industries. The agency's news release describes it as "a direct effort to enhance safety, prevent opioid abuse and combat the nation's growing opioid epidemic."

The rule makes a significant change in the DOT testing scheme that has been in place since it was created in 1988: DOT is removing the requirements for blind specimen testing in order to relieve employers and others of the cost and burden of doing this. Some commenters argued it should be kept in place as a safeguard, but DOT said blind specimen testing isn't needed, citing "rigorous HHS oversight of the laboratories, as well as the business necessity for the laboratories to maintain a reliable record of accuracy."

The rule says DOT will allow oral fluid drug testing and/or hair testing if either is added to the HHS Mandatory Guidelines.

DOT requires urine drug testing of safety-sensitive employees in the transportation industries; the agency had issued an NPRM on Jan. 23, 2017, to harmonize its panel with HHS Mandatory Guidelines, which, because of a revision published the same day and effective on Oct. 1, 2017, allow federal agencies with drug-testing responsibilities to test for the same four opioids.

"The opioid crisis is a threat to public safety when it involves safety-sensitive employees involved in the operation of any kind of vehicle or transport," said Secretary Elaine Chao. "The ability to test for a broader range of opioids will advance transportation safety significantly and provide another deterrence to opioid abuse, which will better protect the public and ultimately save lives."

The final rule means DOT-regulated employers will be required to test for the four opioids starting on Jan. 1, 2018.

Download Center

  • Safety Metrics Guide

    Is your company leveraging its safety data and analytics to maintain a safe workplace? With so much data available, where do you start? This downloadable guide will give you insight on helpful key performance indicators (KPIs) you should track for your safety program.

  • Job Hazard Analysis Guide

    This guide includes details on how to conduct a thorough Job Hazard Analysis, and it's based directly on an OSHA publication for conducting JHAs. Learn how to identify potential hazards associated with each task of a job and set controls to mitigate hazard risks.

  • A Guide to Practicing “New Safety”

    Learn from safety professionals from around the world as they share their perspectives on various “new views” of safety, including Safety Differently, Safety-II, No Safety, Human and Organizational Performance (HOP), Resilience Engineering, and more in this helpful guide.

  • Lone Worker Safety Guide

    As organizations digitalize and remote operations become more commonplace, the number of lone workers is on the rise. These employees are at increased risk for unaddressed workplace accidents or emergencies. This guide was created to help employers better understand common lone worker risks and solutions for lone worker risk mitigation and incident prevention.

  • EHS Software Buyer's Guide

    Learn the keys to staying organized, staying sharp, and staying one step ahead on all things safety. This buyer’s guide is designed for you to use in your search for the safety management solution that best suits your company’s needs.

  • Vector Solutions

Featured Whitepaper

OH&S Digital Edition

  • OHS Magazine Digital Edition - June 2022

    June 2022

    Featuring:

    • SAFETY CULTURE
      Corporate Safety Culture Is Workplace Culture
    • HEAT STRESS
      Keeping Workers Safe from Heat-Related Illnesses & Injuries
    • EMPLOYEE HEALTH SCREENING
      Should Employers Consider Oral Fluid Drug Testing?
    • PPE FOR WOMEN
      Addressing Physical Differences
    View This Issue